Analyst Dhruv Tuli sees breakout potential in JK Paper and Ajanta Pharma. JK Paper has reclaimed key EMAs, with RSI and volume confirming a 35-40% upside. Ajanta Pharma is testing a falling trendline with a bullish RSI divergence. Both stocks are backed by strong technicals for medium-term gains.